Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

Cancer

Volumn 120, Issue 24, 2014, Pages 4006-4007

  Bennett, Charles L ^a   Newsome, Scott D ^b,c   Carson, Kenneth R ^d  

^a University of South Carolina   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTIBODY CONJUGATE;

ADVERSE OUTCOME; BRAIN BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CEREBROSPINAL FLUID ANALYSIS; HUMAN; JC VIRUS; LETTER; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; CHEMICALLY INDUCED;

HUMANS; IMMUNOCONJUGATES; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;

EID: 84919337094     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28947     Document Type: Letter

References (5)

1. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013; 80: 1430-1438.
2. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009; 113: 4834-4840.
3. Carson KR, Focosi D, Major EO, et al. Monoclonal antibodyassociated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol. 2009; 10: 816-824.
4. US Food and Drug Administration. Package Insert for Rituximab. accessdata.fda.gov/drugsatfda-docs/label/2010/103705s5311lbl.pdf. Accessed July 3, 2014.
5. Norris LB, Georgantopoulos P, Rao GA, et al. Association between rituximab use and progressive multifocal leukoencephalopathy among non-HIV, non-Hodgkin lymphoma Veteran's Administration patients. Presented at 2014 American Society of Clinical Oncology Annual Meeting; May 30-June 3, 2014; Chicago, IL. meetinglibrary.asco.org/content/132159-144. Accessed July 3, 2014.